Musculoskeletal disorders (MSDs) can affect people of all ages – the young, working adults, and the elderly. The prevalence of musculoskeletal issues increases with aging, as is evident from the proportion of older adults seeking treatment for MSDs in New York health care centers. With the aging of the US population, it is important to take a proactive approach to the treatment of musculoskeletal disorders and mitigating the risks of these conditions.
Musculoskeletal disorders can affect all parts of the body and include:
- Rheumatoid arthritis, osteoarthritis, gout, and lupus
- Spinal conditions such as low back pain and neck pain
- Scoliosis and other spinal deformities
- Cancers of bone and connective tissue
- Sprains and strains, and other musculoskeletal injuries to the neck, spine, hip, and extremities
Early Detection and Treatment in Crucial
MSDs are painful, restrictive and debilitating, and affect productivity and quality of life. Those affected may find it difficult to even perform every day activities such as walking, getting up from a chair, or self-care. Work-related musculoskeletal disorders such as carpal tunnel syndrome and tendinitis affect performance on the job and lead to days away from work. Moreover, MSDs can have negative effects across the lifespan. For all these reasons, early detection and treatment is crucial.
Fortunately, a NY health care center that has physicians who are experienced and qualified in the diagnosis and treatment of MSDs, follow established, accepted protocols. After diagnosing the condition accurately, they provide patients with an appropriate course of treatment aimed at addressing chronic pain and physical disability. In a professional center, primary care providers, specialists, physical therapists, chiropractors, and alternative caregivers collaborate to develop treatment protocols. This multispecialty approach to evaluation, treatment and follow-up is the key to the successful management of MSDs.
According to a report published by the United States Bone and Joint Initiative (USBJI), musculoskeletal disorder treatment costs plus indirect costs totaled $874 billion in 2015. The report recommends that research should focus on developing more evidence-based interventions and effective treatments for MSDs, while concurrently targeting prevention.